Answers are grounded in this paper and cite their sources.
Integrase strand transfer inhibitors (INSTIs) are a class of antiretroviral agents used to treat HIV. These drugs--raltegravir, elvitegravir, and dolutegravir--are preferred options for treatment-naïve patients when used in combination with two nucleoside reverse transcriptase inhibitors. Based on clinical trials, INSTIs have been proven to be effective with minimal safety concerns. This article reviews the pharmacologic profile, role in therapy, and safety and efficacy of each agent.
No takes yet. Share an insight, caveat, or question.
Wong et al. (2016) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: